Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma [Phase 2]
A Phase 2 trial of a trivalent baculovirus-expressed influenza HA vaccine in adults with Non-Hodgkin's B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 trial evaluating Rituximab (MabThera) in elderly patients with untreated follicular lymphoma has completed. Results from the study h…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment [Phase 1]
Phase I study of ChiLob 7/4, a chimeric anti-CD40 monoclonal antibody, in patients with advanced cancers refractory to conventional treatmen…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives [Phase 2]
Phase 2 clinical trial investigating a two-step bone marrow transplant using cells from two partially matched relatives was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study of Rituximab (MabThera/Rituxan) in patients with relapsed centroblastic-centrocytic non-Hodgkin lymphoma has completed, with r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation [Phase 4]
This Phase 4 trial update reports the completion of the PROMPT study evaluating palifermin for reducing oral mucositis in peripheral blood s…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas [Phase 2]
A Phase II study of PXD101 (belinostat) in recurrent or refractory cutaneous T-cell lymphoma and peripheral T-cell lymphoma was terminated; …
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps [Phase 1, Phase 2]
This Phase 1/2 study evaluated a two-step reduced-intensity conditioning regimen for bone marrow transplantation in patients with hematologi…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating chemotherapy before autologous stem cell transplantation with or without rituximab in relapsed/refractory aggressiv…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial evaluated the combination of fludarabine and rituximab for marginal zone non-Hodgkin's lymphoma (MALT lymphoma) and has c…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma [Phase 3]
Phase 3 trial comparing pegfilgrastim given on Day +3 versus Day +1 after salvage chemotherapy in patients with refractory or relapsed aggre…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy [Phase 2]
Phase 2 trial update shows mild-dose IMRT after GELOX chemotherapy achieving complete tumor response in early-staged extranodal nasal-type N…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) [Phase 1, Phase 2]
Phase 1/2 safety and tolerability study of SNS01-T in relapsed or refractory B-cell malignancies sponsored by Senesco Technologies. The tria…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL [Phase 1]
Phase I trial of Clofarabine with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplant for high-risk or refr…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Investigation of the Cylex® ImmuKnow® Assay
A completed clinical trial investigating the Cylex ImmuKnow immune function assay across several hematologic diseases.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE [NA]
A clinical trial evaluating REGKINE for T-regulatory cell kinetics in stem cell transplantation was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: T-Reg Cell Kinetics, Stem Cell Transplant, REGALE [NA]
A terminated clinical trial (NCT00578539) from Baylor College of Medicine studied regulatory T cell kinetics in stem cell transplantation, w…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating agatolimod sodium in combination with rituximab and Yttrium-90 ibritumomab tiuxetan for adults with re…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma [Phase 2]
This Phase 2 trial update describes BuEAM conditioning with busulfan, etoposide, cytarabine, and melphalan before autologous stem cell trans…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas [Phase 2]
Phase 2 study evaluating induction and maintenance Rituximab (MabThera) in patients with indolent B-cell non-Hodgkin lymphoma; trial complet…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating Oncaspar (pegaspargase), Doxil (liposomal doxorubicin), and Decadron (dexamethasone) in refractory lymphoid maligna…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating combination chemotherapy followed by peripheral stem cell transplantation in children with recurrent or refractory …
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas [Phase 1, Phase 2]
A Phase 1/2 study evaluating CPG 7909 with local radiotherapy for recurrent low-grade lymphomas has completed, with results posted in 2014.